Related Experiment Videos
[Disseminated infection with Mycobacterium celatum]
1Division des maladies infectieuses, Hôpitaux universitaires de Genève.
Schweizerische Medizinische Wochenschrift
|June 15, 1996
Summary
A new atypical mycobacterial species, Mycobacterium celatum, was identified in an AIDS patient with suspected tuberculosis. This finding led to modified treatment, improving the patient's condition.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- A 29-year-old patient diagnosed with Acquired Immunodeficiency Syndrome (AIDS) presented with symptoms including weight loss, fever, and cough.
- Initial mycobacterial cultures from sputum, blood, and bronchoalveolar lavage samples were positive after a 3-week incubation period.
Observation:
- A DNA probe for Mycobacterium tuberculosis complex yielded a weak positive signal, initially suggesting tuberculosis.
- Standard tuberculosis treatment was initiated with isoniazid, ethambutol, and ciprofloxacin.
Findings:
- 16S rRNA gene sequencing identified the causative agent as a novel, slow-growing atypical mycobacterial species, Mycobacterium celatum (M. celatum).
- Mycobacterium celatum exhibited primary resistance to common antituberculous drugs, necessitating a treatment adjustment.
Implications:
- Accurate identification of Mycobacterium celatum is crucial for effective treatment of mycobacterial infections in immunocompromised patients.
- This case highlights the importance of advanced molecular techniques for diagnosing atypical mycobacterial infections that may be misidentified by conventional methods.
- Understanding the drug resistance patterns of Mycobacterium celatum is vital for optimizing therapeutic strategies and improving patient outcomes in AIDS patients.